Levocarnitine and Mercaptopurine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Levocarnitine and Mercaptopurine. Common interactions include hepatic enzyme increased among females and deep vein thrombosis among males.

The phase IV clinical study analyzes what interactions people who take Levocarnitine and Mercaptopurine have. It is created by eHealthMe based on reports of 15 people who take Levocarnitine and Mercaptopurine from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Mar, 03, 2023

15 people who take Levocarnitine and Mercaptopurine together, and have interactions are studied.

What is Levocarnitine?

Levocarnitine has active ingredients of levocarnitine. It is often used in mitochondrial myopathy. eHealthMe is studying from 2,363 Levocarnitine users for its effectiveness, alternative drugs and more.

What is Mercaptopurine?

Mercaptopurine has active ingredients of mercaptopurine. It is often used in crohn's disease. eHealthMe is studying from 20,130 Mercaptopurine users for its effectiveness, alternative drugs and more.

Number of Levocarnitine and Mercaptopurine reports submitted per year:

Common Levocarnitine and Mercaptopurine drug interactions by gender *:

female:

Hepatic enzyme increased
Pyrexia
Nausea
Vomiting
Abdominal pain upper
Blood pressure increased
Decreased immune responsiveness
Heart rate increased
Inflammation
Renal transplant

male:

Deep vein thrombosis
Arthralgia
Cellulitis
Febrile neutropenia
Osteomyelitis
Pain
Abdominal pain
Lipase increased
Pain in extremity
Pancreatitis acute

Common Levocarnitine and Mercaptopurine drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

Deep vein thrombosis
Arthralgia
Cellulitis
Febrile neutropenia
Osteomyelitis
Pain
Pain in extremity

20-29:

Pyrexia
Nausea
Vomiting
Abdominal pain upper
Blood pressure increased
Decreased immune responsiveness
Heart rate increased
Inflammation
Renal transplant
White blood cell count decreased

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

n/a

Common conditions people have *:

Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 11 people, 73.33%
Stress And Anxiety: 6 people, 40.00%
Pain: 6 people, 40.00%
Nausea And Vomiting: 6 people, 40.00%
Nausea (feeling of having an urge to vomit): 6 people, 40.00%
Fever: 6 people, 40.00%
Constipation: 6 people, 40.00%
Asthma: 6 people, 40.00%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 5 people, 33.33%
Carnitine Deficiency: 2 people, 13.33%

* Approximation only. Some reports may have incomplete information.

Do you take Levocarnitine and Mercaptopurine?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.